Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexaria Bioscience Corp. - Common Stock
(NQ:
LEXX
)
0.6800
-0.0300 (-4.23%)
Streaming Delayed Price
Updated: 3:11 PM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexaria Bioscience Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 27, 2025
Via
Benzinga
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
August 14, 2025
Via
ACCESS Newswire
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
August 06, 2025
Via
ACCESS Newswire
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
July 28, 2025
Via
ACCESS Newswire
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
July 23, 2025
Via
ACCESS Newswire
Lexaria Attending BIO International Convention
June 05, 2025
Via
ACCESS Newswire
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
February 27, 2025
Via
ACCESS Newswire
Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm
February 24, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 18, 2025
Via
Benzinga
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
June 23, 2025
Via
ACCESS Newswire
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
June 11, 2025
Via
ACCESS Newswire
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
May 12, 2025
Via
ACCESS Newswire
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
April 28, 2025
Via
ACCESS Newswire
Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
February 20, 2025
Via
ACCESS Newswire
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
February 11, 2025
Via
ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
April 25, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Top stock movements in today's session.
↗
April 25, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
↗
April 25, 2025
Via
Benzinga
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
February 06, 2025
Via
ACCESS Newswire
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
February 05, 2025
Via
ACCESS Newswire
There are notable gap-ups and gap-downs in today's session.
↗
April 25, 2025
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
These stocks that are showing activity before the opening bell on Friday.
↗
April 25, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results
↗
April 25, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 25, 2025
Via
Benzinga
Lexaria Announces $2 Million Registered Direct Offering of Common Stock
April 25, 2025
Via
ACCESS Newswire
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology
April 23, 2025
Via
ACCESS Newswire
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
April 03, 2025
Via
ACCESS Newswire
Lexaria's Human GLP-1 Study #5 Begins Dosing
April 02, 2025
Via
ACCESS Newswire
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
March 18, 2025
Via
ACCESS Newswire
Lexaria Releases Annual Letter from the CEO
January 30, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
